Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2 investigational antibody combination for COVID-19GlobeNewsWire • 08/19/20
Genentech and Regeneron Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Combination for COVID-19Business Wire • 08/19/20
FDA Accepts Evinacumab Biologics License Application for Priority Review as a Treatment for Patients with HoFH, an Ultra-rare Inherited Form of High CholesterolPRNewsWire • 08/12/20
Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/05/20
Regeneron's stock rallies toward a record after profit, revenue beat expectationsMarket Watch • 08/05/20
Regeneron Says Its Coronavirus Antibody Cocktail Shows Promise For Both Prevention, Treatment In Animal TestingBenzinga • 08/04/20
ALERT: Rowley Law PLLC is Investigating Potential Breaches of Fiduciary Duty by Officers and Directors of Regeneron Pharmaceuticals, Inc.Business Wire • 08/03/20
BARDA Procures Regeneron's REGN-EB3 Investigational Ebola Treatment for National PreparednessPRNewsWire • 07/29/20
Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks24/7 Wall Street • 07/24/20